Counselors in East Dixfield, ME Accepting Medicare
1 Counselors found. Showing 1 - 1
 Noreen Ellen Sprague, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 76 East Dixfield Rd, East Dixfield, ME 04227 Phone: 207-491-6425 |
News Archive
Children's Hospital Colorado helps prove safety and efficacy of CF treatment in younger pediatric patients
Researchers at the Children's Hospital Colorado Breathing Institute, the largest pediatric cystic fibrosis (CF) clinical care center in the U.S., participated in the pivotal international multi-center Phase 3 clinical trial, sponsored by Vertex Pharmaceuticals Incorporated, leading to FDA approval of TRIKAFTA (elexacaftor/tezacaftor/ivacaftor), a highly effective CF treatment, for patients ages 6 through 11 who have at least one copy of the F508del mutation.
Northstar Healthcare reports successful syndication of MicroSurgery Institute of Houston
Northstar Healthcare Inc. today announced the successful syndication of its newly formed operating partnership MicroSurgery Institute of Houston ("MSI") with an initial seven physician partners. Northstar will participate in the MSI partnership by leasing the surgery center assets and staff of The Palladium for Surgery - Houston, Ltd. partnership ("Palladium") to MSI for an ownership interest of 25%.
FDA grants fast track designation to Synageva for SBC-102 program for Lysosomal Acid Lipase Deficiency
Synageva BioPharma Corp., a privately held biopharmaceutical company developing therapeutic products for rare disorders, announced today that their lead program, SBC-102, an enzyme replacement therapy for Lysosomal Acid Lipase (LAL) Deficiency, currently in clinical trials, has been granted fast track designation by the U.S. Food and Drug Administration (FDA).
Botox maker agrees to pay $600 million for misbranding
The Associated Press: "Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug. The Justice Department and the company said Wednesday in a statement it will plead guilty to one misdemeanor charge of 'misbranding,' in which the company's marketing led physicians to use Botox for unapproved uses. Those included the treatment of headache, pain, spasticity and cerebral palsy in children.
› Verified 3 days ago